Biosimilars 2024: Potential Growth, Regional Analysis, Competitive Outlook Forecast by 2030

Global Biosimilars Market 2024 research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.

Get a Sample Copy of the Report at – https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/108928

One of the key global biosimilar market trends witnessed is the expiration of biologics patents, which is likely to create new opportunities for companies in this market. A patent typically lasts around 20 years from the moment a company files an application. This period gives exclusive rights to the drug inventor, after which competing companies can launch a biosimilar. Already, these products have been developed for blockbuster biologics, such as Lantus, Rituxan, Herceptin, Remicade, Enbrel, Neulasta, Avastin, and Humira. 

Drivers & Restraints

The global biosimilars market size was valued at USD 20.44 billion in 2022 and is projected to grow from USD 23.96 billion in 2023 to USD 73.03 billion by 2030, exhibiting a CAGR of 17.3% during the forecast period.

This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Biosimilars Market report.

This report focuses on Biosimilars Market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Biosimilars Market market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

Key players covered in the global Biosimilars Market research report:

  • Celltrion Inc. (South Korea)
  • Pfizer Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Amgen Inc. (U.S.)
  • Biocon (India)
  • Biogen (U.S.)
  • Coherus BioSciences (U.S.)
  • Samsung Bioepis (South Korea)
  • Shanghai Henlius Biotech, Inc. (China)

For More Detailed Information, Speak to Our Analyst at - https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/108928

Location: 41 Hendricks Ct, Martinsville, VA 24112, USA

Comments

Post a Comment

Popular posts from this blog

Exploring the Future of Biomedical Research: The Growing Potential of the 3D Cell Culture industry 2024 to 2032

Image
  The 3D Cell Culture market is experiencing robust growth, driven by its transformative impact on biological research and pharmaceutical development. Unlike traditional 2D cell cultures, 3D cell cultures provide a more accurate representation of in vivo cellular environments, allowing cells to grow and interact in three dimensions. This enhanced simulation of physiological conditions improves the relevance of laboratory findings, particularly in areas such as cancer research, tissue engineering, and regenerative medicine. The market encompasses various 3D culture methods, including scaffold-based, scaffold-free, and organ-on-a-chip technologies. Key players are investing heavily in developing innovative products and expanding their application areas, reflecting the growing demand for more predictive and reliable models in drug discovery and development. Get a Sample Copy of the Report at –  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/3d-cell-culture-mar...
Read more

U.S. Ambulatory Surgical Centers Size, Share, Trend, Technological Advancements And Geographical Forecast Till 2030

Image
  Global   U.S. Ambulatory Surgical Centers Market 2024 research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. Get a Sample Copy of the Report at –  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/106323   Drivers & Restraints The global u.s. ambulatory surgical centers market size stood at USD 36.96  Billion in 2021  and is projected to reach USD 58.85  Billion by 2028, exhibiting at a CAGR of 6.9% in the forecast period This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are ...
Read more

Fitness Tracker Global Industry Analysis, Potential Growth, and Key Players Latest Trends Forecast 2030

Image
  Global   Fitness Tracker Market 2024 research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. Get a Sample Copy of the Report at –  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/103358   Drivers & Restraints The global fitness tracker market size stood at USD 53.94  Billion in 2023  and is projected to reach USD 182.90  Billion by 2030, exhibiting at a CAGR of 19.1% in the forecast period This study provides information about the sales and revenue during the historic and forecasted period of (2024 to 2030). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for specific forecast period, market drivers, market restraints, and competitive strategies are assessed in this Fitness Tr...
Read more